State Street Corp Kronos Bio, Inc. Transaction History

State Street Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.92 - $1.5 $3,749 - $6,114	-4,076 Reduced 2.33%	171,225 $171,000
Q2 2024 Aug 14, 2024	SELL	$0.73 - $1.38 $2,190 - $4,140	-3,000 Reduced 1.68%	175,301 $217,000
Q2 2023 Aug 14, 2023	SELL	$1.24 - $1.92 $745,366 - $1.15 Million	-601,102 Reduced 77.12%	178,301 $306,000
Q1 2023 May 15, 2023	BUY	$1.34 - $2.62 $64,843 - $126,784	48,391 Added 6.62%	779,403 $1.14 Million
Q4 2022 Feb 14, 2023	SELL	$1.44 - $3.44 $5,885 - $14,059	-4,087 Reduced 0.56%	731,012 $1.18 Million
Q3 2022 Nov 15, 2022	BUY	$3.35 - $5.55 $52,159 - $86,413	15,570 Added 2.16%	735,099 $2.46 Million
Q2 2022 Aug 15, 2022	SELL	$3.12 - $7.52 $3.77 Million - $9.08 Million	-1,206,870 Reduced 62.65%	719,529 $2.62 Million
Q1 2022 May 16, 2022	BUY	$6.26 - $14.42 $2.82 Million - $6.5 Million	450,780 Added 30.55%	1,926,399 $13.9 Million
Q4 2021 Feb 14, 2022	BUY	$11.35 - $21.18 $9.35 Million - $17.4 Million	823,589 Added 126.31%	1,475,619 $20.1 Million
Q3 2021 Nov 15, 2021	BUY	$18.17 - $24.7 $1.98 Million - $2.69 Million	108,986 Added 20.07%	652,030 $13.7 Million
Q2 2021 Aug 16, 2021	BUY	$20.08 - $29.02 $6.4 Million - $9.25 Million	318,839 Added 142.21%	543,044 $13 Million
Q1 2021 May 17, 2021	SELL	$27.0 - $32.48 $10,800 - $12,991	-400 Reduced 0.18%	224,205 $6.56 Million
Q4 2020 Feb 16, 2021	BUY	$26.68 - $38.23 $5.99 Million - $8.59 Million	224,605 New	224,605 $6.71 Million

889K

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $50M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.